Search:

Pharmaceuticals Headlines from PR Newswire


< Go Back

First Aid Shot Therapy®, Inc. ("F.A.S.T.") Completes Series A Financing Round
Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia
Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer
Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show
Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace
Thought-Leader Opinion and Clinical Data Indicate that Emerging Agents from Two Drug Classes Have Efficacy Advantages Over Currently Used Therapies for HR-Positive, HER2-Negative Breast Cancer
The Zacks Analyst Blog Highlights: Actavis, BP, Total, Petrobras and Devon Energy
Avion Pharmaceuticals, LLC., launches Prenate Chewable™, the newest addition to the Prenate® Prenatal Vitamin Family
Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors
New Data Validates CyberKnife SBRT for Prostate Cancer Treatment
Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
Diclegis® Now Available Nationwide To Treat Pregnant Women With Nausea And Vomiting Of Pregnancy (NVP)
BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference
U.S. Spending on Specialty Medications Likely to Increase 67 Percent Through 2015
Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets
Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain
Federal Appellate Court Rules in Favor of Mylan in Patent Infringement Litigation Relating to Sunovion's Brovana® Product
Complix to Present at Upcoming BioEquity Europe 2013
Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study
RxAlly Releases White Paper on Necessity of Personalized Pharmacist Care
Research-based Pharmaceutical Industry Launches 'Do You Mind?' Campaign to Fight Mental and Neurological Disorders
Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss
Upsher-Smith Introduces Newly Redesigned Corporate Website
Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans
TRACE Releases 2012 Global Enforcement Report
Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
CVS/pharmacy® Reminds Patients with Diabetes about the Importance of Regular Testing to Help Manage Their Disease
For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs
AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
Survey: 85% of Part D Seniors in Preferred Pharmacy Plans are Satisfied With Costs, Pharmacy Choices
Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania
Rosetta Genomics Announces Credentialing Agreement with Prime Health Services for miRview mets2
Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S.
TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace
Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes
From Research Labs to Doctors' Offices, Health Care Providers at Lilly Play Important Role in Bringing New and Innovative Medicines to Patients
Rexahn Pharmaceuticals To Present At The Second Annual Marcum LLP MicroCap Conference
Sports Medicine New Frontiers: Platelet-Rich-Plasma (PRP) and Stem Cell Therapy
TRACON Pharmaceuticals Announces TRC105 Clinical Trials, Abstract Presentations at 2013 ASCO Annual Meeting
Life Technologies Announces Regulatory Approval of 3500 Dx Series Genetic Analyzers in Mexico
Intercept Pharmaceuticals Announces Positive Initial Results from Ongoing Phase 2a Trial in Chronic Bile Acid Diarrhea
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
Actavis to Acquire Warner Chilcott to Create Premier $11 Billion Revenue Global Specialty Pharmaceutical Company
Value Edge launches Pharma Analytics Blog, Pharma Musings
New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines Portuguese Spanish
Final STRATO Clinical Study Data Demonstrates Potential for LCP-Tacro™ to Improve Tacrolimus-Induced Tremors

< Prev Next >
PR Newswire - United Business Media